249
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Validation of assistive technology on psychoactive substances for visually impaired people

&
Pages 236-240 | Received 28 Jun 2017, Accepted 20 Dec 2017, Published online: 26 Dec 2017
 

Abstract

Purpose: To validate the assistive technology “Drugs: reflection for prevention” to be used with visually impaired people.

Method: Quantitative and quasi-experimental study, contrasting knowledge before and after the use of the assistive technology with 140 visually impaired people in institutes and associations for people with visual impairment. A questionnaire with identification data, a pre-test, a post-test and a questionnaire to assess the assistive technology were applied. Data were described through means and standard deviations, and analyses included the McNemar test, the exact binomial distribution test, and the intraclass correlation coefficient.

Results: Participants were male (65.7%), 84.3% were blind, aged 37.1 years on average and with schooling of 10.1 years on average. There were more correct answers in the post-test (p <.001). The attributes of the assistive technology were considered adequate: objectives, access, clarity, structure and presentation, relevance and efficacy, and interactivity (p <.001).

Conclusions: The assistive technology “Drugs: reflection for prevention” was considered valid and reliable to inform visually impaired people about psychoactive substance abuse.

    Implications for rehabilitation

  • Created new tool for prevention substance abuse that can be accessed easily.

  • Improved information about substance psychoactive for users of the assistive technology.

  • Improved quality of life for its users.

Disclosure statement

No potential conflict of interest was reported by the authors.

Ethical considerations

This study was approved by the Ethics Committee of the Federal University of Pernambuco, CAAE 08796212.2.0000.5208.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.